Format

Send to

Choose Destination
Cell. 2014 Jun 19;157(7):1591-604. doi: 10.1016/j.cell.2014.04.042.

Polar body genome transfer for preventing the transmission of inherited mitochondrial diseases.

Author information

1
State Key Laboratory of Medical Neurobiology, Department of Neurobiology, Institutes of Brain Science, School of Basic Medical Sciences and Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200032, China.
2
State Key Laboratory of Medical Neurobiology, Department of Neurobiology, Institutes of Brain Science, School of Basic Medical Sciences and Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200032, China. Electronic address: shahongying@fudan.edu.cn.
3
Center for Reproductive Medicine, Department of Obstetrics and Gynecology, the First Hospital Affiliated for Anhui Medical University, Hefei 230022, China.
4
Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.
5
State Key Laboratory of Medical Neurobiology, Department of Neurobiology, Institutes of Brain Science, School of Basic Medical Sciences and Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai 200032, China. Electronic address: jzhu@fudan.edu.cn.

Abstract

Inherited mtDNA diseases transmit maternally and cause severe phenotypes. Currently, there is no effective therapy or genetic screens for these diseases; however, nuclear genome transfer between patients' and healthy eggs to replace mutant mtDNAs holds promises. Considering that a polar body contains few mitochondria and shares the same genomic material as an oocyte, we perform polar body transfer to prevent the transmission of mtDNA variants. We compare the effects of different types of germline genome transfer, including spindle-chromosome transfer, pronuclear transfer, and first and second polar body transfer, in mice. Reconstructed embryos support normal fertilization and produce live offspring. Importantly, genetic analysis confirms that the F1 generation from polar body transfer possesses minimal donor mtDNA carryover compared to the F1 generation from other procedures. Moreover, the mtDNA genotype remains stable in F2 progeny after polar body transfer. Our preclinical model demonstrates polar body transfer has great potential to prevent inherited mtDNA diseases.

PMID:
24949971
DOI:
10.1016/j.cell.2014.04.042
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center